Last reviewed · How we verify
Phase1 Study of Recombinant Stem Cells That Repair Lung Injury in H7N9 Infected Patients
The purpose of this study is to determine whether human menstrual blood-derived stem cells are effective in the treatment of infection of H7N9 virus caused acute lung injury.
Details
| Lead sponsor | S-Evans Biosciences Co., Ltd. |
|---|---|
| Phase | Phase 1/Phase 2 |
| Status | UNKNOWN |
| Enrolment | 20 |
| Start date | 2014-03 |
| Completion | 2016-12 |
Conditions
- Acute Lung Injury
- Acute Respiratory Distress Syndrome (ARDS)
- Multiple Organ Failure
Interventions
- Menstrual blood stem cells
Primary outcomes
- The degree of lung injury — 14 days
Countries
China